If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Interim Management Statement

18 Jul 2013 07:00

RNS Number : 5720J
Biome Technologies PLC
18 July 2013
 



18 July 2013

 

Biome Technologies plc ("Biome", "the Company" or "the Group")

Interim Trading Statement

 

 

Biome Technologies plc, a leading bioplastics and RF technology business, today publishes a trading update, ahead of its interim results for the six-month period ended 30 June 2013, which are expected to be announced on 2 September 2013.

 

Trading Update

 

Total Group revenues achieved for the second quarter were £0.5m (Q1 2013: £0.4m). As previously noted, this year is anticipated to be second half weighted and the Board expects revenue growth in both divisions as the year progresses.

 

On 23 May 2013 the Board, having completed a settlement with regard to two legacy long leases on buildings in Southampton for a cash sum of £895,000, plus VAT, proposed a process of capital reduction, consolidation and sub-division of existing ordinary shares. This process was approved by Shareholders on 20 June and the consolidated shares admitted to AIM on 16 July 2013.

 

The Board is pleased to confirm that the Court approved the proposed capital reduction on 17 July 2013. This decision will allow us to complete the process, which the Board believes will provide a clearer view of the Company's financial position and rationalise the unusually large shareholder base of the Company.

 

The Group's cash position at 30 June 2013 was £3.9m (31 March 2013: £5.8m).

 

We continue to make progress with the strategy to commercialise and develop wholly owned intellectual property and our performance remains in line with the Board's expectations.

 

Bioplastics Division

 

The Q2 2013 revenues for the Bioplastics Division were £0.1m (Q1 2013: £0.2m). This division is focused on developing high margin, application led products with enhanced level of functionality. Two key projects are currently being undertaken for single use foodservice products and single use coffee capsules.

 

The first of these projects remains in the development phase with biodegradation certification now completed and composting trials underway. This project is expected to remain under development until the final quarter of 2013.

 

The second project required significant technical support in the second quarter to ensure optimisation of our customer's manufacturing performance in the USA. This project is now passing into the manufacturing phase and shipments of substantially increased tonnages for the second half are in prospect.

 

In the first quarter, the division was awarded a grant by the Government-backed Technology Strategy Board (TSB). Work on this project started in the second quarter in conjunction with the University of Warwick's Centre for Biotechnology and Biorefining and the Group has subsequently applied for a further grant to broaden this work. The result of this application is expected in the near future.

 

Stanelco RF Technologies Division

 

The Q2 revenues for the RF Division were £0.4m (Q1 2013: £0.2m). As previously reported, a number of optical fibre furnace deliveries were delayed at the end of 2012 due to some uncertainties in the Chinese fibre market. Some pick-up was evident in the second quarter and Stanelco RF has tendered for a number of significant projects for the second half but the market is yet to return to the levels seen previously.

 

Progress continues on the Durapipe project with results from time-based testing of the final pipe-work made with the Stanelco prototypes awaited. Transition to commercial production on this project is expected in the second half. Enquiry and order levels for general industrial equipment are robust and the partnership with Forsstrom continues to build.

 

-Ends-

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

 

 

David Hart/James Thomas

 

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

 

 

First Columbus

 

Chris Crawford/Kelly Gardiner

 

www.first-columbus.com

Tel: +44 (0) 20 3002 2070

 

 

FTI Consulting

 

Oliver Winters/Latika Shah

Tel: +44 (0) 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDRXDBBGXR
Date   Source Headline
14th Jun 201012:31 pmRNSResult of Meeting
14th Jun 20107:00 amRNSResult of the Firm Placing, Placing and Open Offer
27th May 20104:15 pmRNSPublication of Prospectus
27th May 20107:00 amRNSFirm Placing and Placing and Open Offer
25th May 20104:40 pmRNSSecond Price Monitoring Extn
25th May 20104:35 pmRNSPrice Monitoring Extension
21st May 20104:40 pmRNSSecond Price Monitoring Extn
21st May 20104:35 pmRNSPrice Monitoring Extension
30th Apr 20104:40 pmRNSSecond Price Monitoring Extn
30th Apr 20104:35 pmRNSPrice Monitoring Extension
30th Apr 201010:36 amRNSAnnual Report and Accounts
29th Apr 20107:01 amRNSInterim Management Statement
29th Apr 20107:00 amRNSPreliminary Results
19th Apr 20107:00 amRNSUpdate re Novamont S.p.A infringement claims
16th Apr 20107:00 amRNSAnnual Information Update
17th Feb 20108:00 amRNSBiome Bioplastics new HT bioplastic
25th Jan 201010:30 amRNSStanelco re-brands bioplastics business
9th Dec 20098:00 amRNSOrders for Fibre Optics systems in Asia
3rd Dec 20097:00 amRNSStatement re share price movement
25th Nov 20094:40 pmRNSSecond Price Monitoring Extn
25th Nov 20094:35 pmRNSPrice Monitoring Extension
9th Nov 200910:06 amRNSHolding(s) in Company
6th Nov 20097:00 amRNSInterim Management Statement
21st Oct 20093:17 pmRNSHolding(s) in Company
20th Oct 20094:35 pmRNSPrice Monitoring Extension
8th Sep 20094:45 pmRNSHolding(s) in Company
4th Sep 20094:35 pmRNSPrice Monitoring Extension
3rd Sep 20094:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20094:35 pmRNSPrice Monitoring Extension
28th Aug 20097:00 amRNSInterim Results
13th Aug 20094:40 pmRNSSecond Price Monitoring Extn
13th Aug 20094:35 pmRNSPrice Monitoring Extension
7th May 20097:00 amRNSDirectors' Dealing
24th Apr 20091:42 pmRNSResult of Annual General Meeting
24th Apr 20097:00 amRNSInterim Management Statement
7th Apr 20097:00 amRNSAnnual Information Update
2nd Apr 20092:01 pmRNSDirector/PDMR Shareholding
1st Apr 20097:00 amRNSChange of Adviser
30th Mar 20095:36 pmRNSAnnual Report and Accounts and Notice of AGM
26th Mar 20094:35 pmRNSPrice Monitoring Extension
26th Mar 20097:00 amRNSPreliminary Results
19th Dec 20087:01 amRNSDirectorate Change
19th Dec 20087:00 amRNSDirectorate Change
7th Nov 20087:00 amRNSInterim Management Statement
10th Oct 200811:14 amRNSDirector/PDMR Shareholding
2nd Sep 200812:02 pmRNSHolding(s) in Company
29th Aug 20087:00 amRNSInterim Results
22nd Aug 20081:36 pmRNSHolding(s) in Company
30th Jul 20089:02 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.